Multinational study for Glanzmann thrombasthenia patients
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study is for adults with Glanzmann thrombasthenia, a rare bleeding disorder. It aims to learn more about the condition and how to care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years or older.
- You must have a confirmed diagnosis of Glanzmann thrombasthenia from blood tests or genetic testing.
- You must be willing and able to give your permission to join the study.
- You cannot have bleeding problems caused by an autoimmune disease or medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This trial is testing a medication called eptacog beta (a clotting factor) to see if it helps control or prevent severe bleeding episodes in people with Glanzmann's thrombasthenia, a rare inherited bleeding disorder.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
This trial is studying children with Glanzmann thrombasthenia who are currently having bleeding episodes. It aims to understand the pattern of bleeding and how the condition shows up in children.
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
Hear when a new Glanzmann Thrombasthenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.